If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

Share Price is delayed by 15 minutes
Get Live Data
33.00    5.50 (20.75%)
Bid:
31.00
Ask:
33.00
Spread: 2.00 (6.452%)
Market Cap: £3.03m
CPP Live PriceLast checked at - London Stock Exchange

Intraday Cppgroup Share Chart

Agreement with the FSA

24 Feb 2012 07:00

RNS Number : 0550Y
CPPGroup Plc
24 February 2012
 



CPPGroup plc - Agreement with the FSA

24 February 2012

Further to the announcement on 20th February, CPPGroup plc ("CPP" or the "Group") announces that it has reached agreement in principle with the FSA in relation to the scope of actions necessary to address certain failings in CPP's sales processes.

In relation to both its Card Protection and Identity Protection products, CPP has agreed with the FSA to undertake a past business review whereby CPP will contact customers whom CPP approached directly to purchase the products.

CPP has also agreed to implement with FSA oversight a number of changes to its renewals process, in order to highlight more clearly to customers that they have the right not to renew the product, and to explain clearly to the customer the advantages and limitations of the relevant product. CPP will now work with the FSA to agree the detail of these proposals.

Further, CPP has agreed to certain restrictions on the disposition of assets, including in relation to the payment of dividends. In particular, shareholders should be aware that the Group will not declare or pay any final dividend in respect of the financial year ended 31 December 2011.

CPP considers this agreement to be a positive development. The resolution of these issues allows CPP to renew its focus on evolving towards a more customer centric business.

In assessing the likely financial impact, CPP has with its advisors considered a number of assumptions, including as to customer response rates to the past business review and any impact on renewal take up rates. Based on those initial assumptions, CPP estimates that the financial exposure of the Group resulting from customer compensation, potential loss of renewal business and costs associated with carrying out the past business review, is expected be in the range of £10 million to £15 million.

CPP remains in discussions with various stakeholders, including its financing banks and business partners, as to the ultimate impact on the business of the FSA's investigation. Until those discussions have concluded it is expected that the suspension of CPP's shares remains in place.

Further announcements will be made in due course.

 

Enquiries:

 

Paul Stobart, Group Chief Executive

Shaun Parker, Chief Financial Officer

Tel. +44 (0)20 7353 4200 (today)

Tel: +44 (0)1904 544702 (thereafter)

 

Tulchan Communications

John Sunnucks

David Allchurch

Martin Robinson

Tel. +44 (0)20 7353 4200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLIFFRFSISFIF
Date   Source Headline
18th Mar 20217:00 amRNSChange of Adviser
17th Mar 20217:00 amRNSDirectorate Change
5th Mar 20217:00 amRNSDirectorate Change - Amendment
11th Feb 20217:00 amRNSBlock listing Interim Review
5th Feb 20218:34 amRNSDirectorate Change
18th Jan 20217:00 amRNSTrading Update
21st Dec 20205:32 pmRNSDirector/PDMR Shareholding
17th Dec 202012:26 pmRNSBlock listing Interim Review
30th Nov 20203:47 pmRNSDirectorate Change
13th Nov 20207:00 amRNSDirectorate Change
2nd Nov 202011:38 amRNSTotal Voting Rights
26th Oct 20201:30 pmRNSBlock listing Interim Review
5th Oct 202011:09 amRNSTotal Voting Rights
24th Sep 20207:00 amRNSHalf-year Report
9th Sep 202012:02 pmRNSNon Regulatory - Blink - Lloyds Lab
18th Aug 202010:19 amRNSBusiness Update
13th Aug 20207:17 amRNSBlock listing Interim Review
1st Jul 20208:29 amRNSTotal Voting Rights
30th Jun 20208:08 amRNSBlock listing Interim Review
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
9th Jun 20209:37 amRNSDirectorate Change
28th May 202012:32 pmRNSResult of AGM
22nd May 202012:28 pmRNSTotal Voting Rights
20th May 202012:08 pmRNSSecond Price Monitoring Extn
20th May 202012:02 pmRNSPrice Monitoring Extension
19th May 202011:10 amRNSBusiness Update
1st May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:42 pmRNSNotice of AGM
21st Apr 20202:48 pmRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSFinal Results
14th Apr 20203:36 pmRNSAdditional Listing
23rd Mar 20201:17 pmRNSTrading Statement
23rd Mar 20207:00 amRNSStatement re delayed preliminary results
12th Mar 202010:13 amRNSAdditional Listing
24th Feb 202011:40 amRNSBusiness Update
11th Feb 20204:24 pmRNSBlock listing Interim Review
10th Feb 202012:43 pmRNSCPP Group India Risk award
6th Feb 20204:41 pmRNSSecond Price Monitoring Extn
6th Feb 20204:35 pmRNSPrice Monitoring Extension
3rd Feb 20201:22 pmRNSCPP advances technology offering in Turkey
20th Dec 20199:50 amRNSDirector/PDMR Shareholding
16th Dec 201912:08 pmRNSBlock listing Interim Review
12th Dec 201911:16 amRNSDirector/PDMR Shareholding
28th Nov 201911:03 amRNSBusiness Update
12th Nov 20192:40 pmRNSBusiness Update
4th Nov 20194:11 pmRNSTotal Voting Rights
21st Oct 20192:16 pmRNSBusiness update
18th Oct 201912:07 pmRNSSecond Price Monitoring Extn
18th Oct 201912:02 pmRNSPrice Monitoring Extension
1st Oct 20199:04 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.